BioMarin Joins Oligonucleotide Manufacturing Collaboration
BioMarin joined an industrial collaboration with CPI, AstraZeneca, Novo Nordisk and Novartis to scale and commercialize enzyme-driven manufacturing technology for therapeutic oligonucleotides.